10 drug(s) with this reaction
11,639 total reports
Swelling has been reported as an adverse reaction across 10 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 11,639 adverse event reports mention swelling in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with swelling, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have swelling listed in their FDA adverse event reports, sorted by report count:
In addition to swelling, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
10 drug(s) manufactured by Haleon Us Holdings Llc have swelling listed in their FDA adverse event reports: DICLOFENAC SODIUM, CALCIUM CARBONATE, FLUTICASONE PROPIONATE, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, and others.
There are a combined 11,639 reports of swelling across 10 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.